Article
Mutation of the mitochondrial large ribosomal RNA can provide pentamidine resistance to Saccharomyces cerevisiae.
Mitochondrion - 1 Sept 2014
Örs Ş Tomris, Akdoğan Emel, Dunn Cory D
Abstract excerpt
Pentamidine is used to treat several trypanosomal diseases, as well as opportunistic infection by pathogenic fungi. However, the relevant targets of this drug are unknown. We isolated dominant mutations providing pentamidine resistance to Saccharomyces cerevisiae, one of which was localized to mitochondrial DNA. Next-generation sequencing revealed alteration of a widely conserved base at the peptidyl transferase...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
